Scrip“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning
Scrip“I’m optimistic when it comes to both the integration and the impact of transformative technologies across the life sciences industry,” said Jessica Federer , Bayer ’s former chief digital officer a
Medtech InsightIt has been several years since Medtronic has not topped the annual Medtech 100 ranking of global medical device, diagnostic and digital health companies by revenues. But that was the outcome after
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Buys Cystinosis Gene Therapy F